The loss of funding appears poised to impact disease spread, resistance, and death rates, in part through its impact on diagnostic testing.
Public health labs have handled most testing thus far for the Texas and New Mexico outbreaks, but commercial labs are beginning to bring molecular measles assays online.
The firm has multiple infectious disease tests in its pipeline and is currently in initial conversations with potential investors and partners.
UK Prime Minister Keir Starmer announced last week his plans to scrap the body, a dozen years after it was established to lead the National Health Service in England.
Leaders from diagnostics firms and academia discussed the challenges of assessing these tests and the need for a consensus on how to bring them to the clinic.
The test can be used to better stratify cancer patients and determine the likelihood of breast cancer metastasizing.
The company said it expects its first quarter revenue to be down 10 percent to 15 percent year over year due in part to a decline in US academic sales.